DISTRIBUTION, LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT between ASTRAZENECA UK LIMITED and Impax LABORATORIES, INC. Dated as of January 31, 2012Development and Supply Agreement • February 6th, 2012 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware
This Distribution, License, Development and Supply Agreement (the “Agreement”) is made and entered into effective as of January 31, 2012 (the “Effective Date”) by and between AstraZeneca UK Limited, a company incorporated in England under no. 3674842 whose registered office is at 2 Kingdom Street, London, W2 6BD, England (“AstraZeneca”), and Impax Laboratories, Inc., a Delaware corporation located at 30831 Huntwood Avenue, Hayward, CA 94544 (“Impax”). AstraZeneca and Impax are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
